Brazilian parliamentary commission approves 1st phase of anti-viral drug factory in Mozambique

31 August 2009

Brasilia, Brazil, 31 Aug – A commission of the Brazilian parliament last week approved the draft law that authorises the country to donate US$7.47 million for the first phase of installation of anti viral drugs factory in Mozambique.

According to Agência Câmara – the Brazilian parliament’s news service – the project will now be forwarded to the Brazilian Senate, where it will also be evaluated.

The Oswaldo Cruz Foundation (Fiocruz) – a health science and technology institute linked to the Brazilian government and which has carried out various cooperation projects in Mozambique, including setting up the factory – estimates that the first phase of the factory will cost around US$9 million, of which US$2 million will be provided by the Mozambican government, including construction work, equipment, utensils and medication.

The factory has been under discussion since 2003 during an official visit by Brazilian President Luiz Inácio Lula da Sila to Mozambique.

Menawhile, only in the last few months has it been possible to estimated that in the next year the first stage of production of anti-virals will begin in Mozambique, which is the process of packaging the medication.

As well as the factory, Fiocruz supports other programmes related to HIV and AIDS in Mozambique, such as the Health Sciences Masters Degree, in cooperation with the National Health Institute (INS), training professionals in Mother and Baby health, creation of the National Institute of Women and Children, in partnership with MISAU and the Trilateral agreement between Mozambique, Brazil and the United States. (macauhub)